Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, A R-
dc.contributor.authorVavia, P R-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.description.abstractPharmaceutical inhalation aerosols have been playing a crucial role in the health and well being of millions of people throughout the world for many years. The technology’s continual advancement, the ease of use and the more desirable pulmonary-rather-than-needle delivery for systemic drugs has increased the attraction for the pharmaceutical aerosol in recent years. But administration of drugs by the pulmonary route is technically challenging because oral deposition can be high, and variations in inhalation technique can affect the quantity of drug delivered to the lungs. Recent advances in nanotechnology, particularly drug delivery field have encouraged formulation scientists to expand their reach in solving tricky problems related to drug delivery. Moreover, application of nanotechnology to aerosol science has opened up a new category of pharmaceutical aerosols (collectively known as nanoenabled-aerosols) with added advantages and effectiveness. In this review, some of the latest approaches of nano-enabled aerosol drug delivery system (including nano-suspension, trojan particles, bioadhesive nanoparticles and smart particle aerosols) that can be employed successfully to overcome problems of conventional aerosol systems have been introduced.en_US
dc.sourceIJEB Vol.45(02) [February 2007]en_US
dc.subjectBioadhesive nanoparticlesen_US
dc.subjectInhalation aerosolsen_US
dc.subjectSmart particle aerosolsen_US
dc.subjectTrojan particlesen_US
dc.titleNanotechnology and pharmaceutical inhalation aerosolsen_US
Appears in Collections:IJEB Vol.45(02) [February 2007]

Files in This Item:
File Description SizeFormat 
IJEB 45(2) 166-174.pdf285.21 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.